Literature DB >> 11020560

Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer.

C M Nutting1, D J Convery, V P Cosgrove, C Rowbottom, A R Padhani, S Webb, D P Dearnaley.   

Abstract

PURPOSE: To investigate the role of intensity-modulated radiation therapy (IMRT) to irradiate the prostate gland and pelvic lymph nodes while sparing critical pelvic organs, and to optimize the number of beams required. METHODS AND MATERIALS: Target, small bowel, colon, rectum, and bladder were outlined on CT planning scans of 10 men with prostate cancer. Optimized conventional (RT) and 3-dimensional conformal radiotherapy (3D-CRT) plans were created and compared to inverse-planned IMRT dose distributions using dose-volume histograms. Optimization of beam number was undertaken for the IMRT plans.
RESULTS: With RT the mean percentage volume of small bowel and colon receiving >45 Gy was 21.4 +/- 5.4%. For 3D-CRT it was 18.3 +/- 7.7% (p = 0.0043) and for 9-field IMRT it was 5.3 +/- 1.8% (p < 0.001 compared to 3D-CRT). For 7, 5, and 3 IMRT fields, it was 6.4 +/- 2.9%, 7.2 +/- 2.8%, and 8.4 +/- 3.8% (all p < 0.001 compared to 3D-CRT). The rectal volume irradiated >45 Gy was reduced from 50.5 +/- 16.3% (3D-CRT) to 5.8 +/- 2.1% by 9-field IMRT (p < 0. 001) and bladder from 52.2 +/- 12.8% to 7 +/- 2.8% (p < 0.001). Similar benefits were maintained for 7, 5, and 3 IMRT fields.
CONCLUSIONS: The reduction in critical pelvic organ irradiation seen with IMRT may reduce side effects in patients, and allow modest dose escalation within acceptable complication rates. These reductions were maintained with 3-5 IMRT field plans which potentially allow less complex delivery techniques and shorter delivery times.

Entities:  

Mesh:

Year:  2000        PMID: 11020560     DOI: 10.1016/s0360-3016(00)00653-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  41 in total

Review 1.  Radiation medicine innovations for the new millenium.

Authors:  Dwight E Heron; Karen D Godette; Ray A Wynn; V Elayne Arterbery; Oscar A Streeter; Mack Roach; Joseph R Simpson; Melissa Blough; Charles R Thomas
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

2.  Tissue toxicity induced by ionizing radiation to the normal intestine: understanding the pathophysiological mechanisms to improve the medical management.

Authors:  M-C Vozenin-Brotons
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 3.  Maintenance of radiation-induced intestinal fibrosis: cellular and molecular features.

Authors:  Valérie Haydont; Marie-Catherine Vozenin-Brotons
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

4.  Automated prediction of dosimetric eligibility of patients with prostate cancer undergoing intensity-modulated radiation therapy using a convolutional neural network.

Authors:  Tomohiro Kajikawa; Noriyuki Kadoya; Kengo Ito; Yoshiki Takayama; Takahito Chiba; Seiji Tomori; Ken Takeda; Keiichi Jingu
Journal:  Radiol Phys Technol       Date:  2018-08-14

5.  Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?

Authors:  G Eminowicz; C Dean; O Shoffren; N Macdougall; P Wells; R Muirhead
Journal:  Br J Radiol       Date:  2014-03-20       Impact factor: 3.039

6.  Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.

Authors:  C Franzese; A Fogliata; G R D'Agostino; L Di Brina; T Comito; P Navarria; L Cozzi; M Scorsetti
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-08       Impact factor: 4.553

7.  Radiation colitis and proctitis.

Authors:  Gregory D Kennedy; Charles P Heise
Journal:  Clin Colon Rectal Surg       Date:  2007-02

8.  Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer.

Authors:  Dong Wook Kim; Weon Kuu Chung; Dongoh Shin; Seongeon Hong; Sung Ho Park; Sung-Yong Park; Kwangzoo Chung; Young Kyung Lim; Dongho Shin; Se Byeong Lee; Hyun-Ho Lee; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

9.  Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer.

Authors:  Matthew D Schmitz; Gilbert D A Padula; Patrick Y Chun; Alan T Davis
Journal:  Radiat Oncol       Date:  2010-09-16       Impact factor: 3.481

Review 10.  Gastrointestinal radiation injury: prevention and treatment.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.